What HER2 breast cancer patients really think shapes treatment strategy

A new European study documents how HER2-positive breast cancer patients perceive their disease, treatment, and future—revealing insights that could reshape how doctors engage patients and design care pathways. Patient perspectives on treatment burden and quality of life have direct implications for clinical decision-making, drug development priorities, and healthcare resource allocation across Europe.

Originaltitel: Plain language summary about how patients with HER2 positive breast cancer across Europe feel about their cancer, treatment, and future health and related implications for their treatment journey